Acceleron Pharma Inc Conference Call and Webcast to Review New Luspatercept Data Presented at the 20th Congress of the European Hematology Association Today's Calls 
Visit the TF Network Sites
Visit the TF Network Sites
· Corporate IR Center
· Institutional Investor Center
· Individual Investor Center
Download Plug-In
Real Player 8 Basic
Windows Media Player
Other Conference Calls
Other Jun 15 Calls
Today's Calls
Call Details
Acceleron Pharma Inc Conference Call and Webcast to Review New Luspatercept Data Presented at the 20th Congress of the European Hematology Association
Mon, Jun 15, 2015, 10:00 am Eastern

Listen to the archived event audio


About Acceleron Pharma Inc (NasdaqGM:XLRN)
Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. The company is developing luspatercept and sotatercept therapeutic candidates, which are in Phase 3 clinical trials used to treat anemia and associated complications in patients with ß-thalassemia and myelodysplastic syndromes. The sotatercept therapeutic candidate is also used to increase bone mineral density; and to treat the final stage of chronic kidney disease and end-stage renal disease. It is also developing dalantercept therapeutic candidate to treat renal cell carcinoma and hepatocellular carcinoma; and ACE-083 that is in Phase 1 clinical trial used to promote muscle growth and function in specific treated muscle groups. It has collaboration, license, and option agreement with Celgene Corporation. The company was formerly known as Phoenix Pharma, Inc. Acceleron Pharma Inc. was founded in 2003 and is headquartered in Cambridge, Massachusetts.


More Info: Quote | Profile | Research | Insider | Financials


Copyright © 2015 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Copyright © 2015 FirstCall Events. Historical chart data provided by Commodity Systems, Inc. (CSI). Company profile information presented on this page is Copyright Capital IQ. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.